Comparison

Vazegepant European Partner

Item no. M28198-5mg
Manufacturer AbMole
CASRN 1337918-83-8
Amount 5mg
Specific against other
Purity ≥99.0%
Alias Zavegepant; BHV-3500
Available
Target Information
CGRP Receptor
Molecular Weight
638, 8
Bioactivity information
Vazegepant is the first intranasal CGRP receptor antagonist for the study the acute research of migraine.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close